Lupin Limited on May 5, 2023, announced that it has entered into a definitive agreement to acquire the entire share capital of the French pharmaceutical company, Medisol, subject to approval from the French Ministry of Economy and Finance.
Lupin Limited that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Tenofovir Alafenamide Tablets,25 mg, a generic equivalent of Vemlidy Tablets, 25 mg, of Gilead Sciences, Inc.
Lupin Limited announced the launch of its new state-of-the-art Regional Reference Laboratory in Bengaluru, Karnataka on April 12, 2023, as part of the expansion of its diagnostics network.
Lupin Diagnostics launches new regional reference laboratory in Hyderabad
Lupin launched a fixed-dose triple drug combination to treat uncontrolled asthma
Lupin gets USFDA nod for generic version of Robinul Injection
Lupin gets tentative approval from USFDA for generic equivalent of HIV treatment drug
Lupin launches digital therapeutics solution LYFE for heart patients
Lupin gets US FDA nod for generic medicine to treat heart ailments
Lupin gets USFDA nod for generic drug to treat bladder problems
|